Mallinckrodt shakes up pharma world with $925m deal – Therakos’ new era begins!
Mallinckrodt plc, a prominent global specialty pharmaceutical firm, has announced a major deal with CVC Capital Partners, one of the world's leading investment firms. Under ... Read More
Mallinckrodt to acquire Sucampo Pharmaceuticals in $1.2bn deal
In a strategic move to broaden its pharmaceutical offerings, UK-based Mallinckrodt has announced the acquisition of Sucampo Pharmaceuticals, including its commercial and developmental assets, for ... Read More